Theracare Medicated Chest Rub

Description

TheraCare Medicated Chest Rub is a topical formulation designed for application to the chest area. The product is presented in a 3.53 oz container and is intended for use in providing relief from respiratory discomfort. The effective date of this formulation is March 1, 2023. The labeling includes a reference image in JPEG format, identified as 19-205353 LBL chest rub 3.53oz.jpg.

Uses and Indications

This drug is indicated for the temporary relief of throat and chest cough associated with nasal congestion due to the common cold. It is also effective in alleviating aching muscles and minor aches and pains.

Limitations of Use: This medication is intended for symptomatic relief and does not address the underlying causes of these conditions. It is recommended for use in adults and children as directed.

Dosage and Administration

Adults and children aged 2 years and older are instructed to apply a thick layer of the product topically on the chest and throat or on sore, aching muscles. If desired, the application may be covered with a dry, soft cloth; however, it is important to ensure that clothing remains loose. This application may be repeated up to three times daily.

For children under 2 years of age, it is recommended to consult a physician prior to using this product.

Contraindications

Use of this product is contraindicated in the following situations:

Administration by mouth, application in nostrils, or on wounds or damaged skin is prohibited due to the potential for adverse effects and complications. Additionally, the use of tight bandages in conjunction with this product is contraindicated, as it may lead to increased pressure and irritation.

When utilizing this product, it is essential to avoid exposure to heat, microwaving, or proximity to open flames. Furthermore, adding the product to hot water or any container that may cause splattering when heated is contraindicated, as this poses a risk of burns.

Warnings and Precautions

For external use only; direct contact with the eyes should be strictly avoided. In the event of accidental ingestion, it is imperative to seek medical assistance immediately or contact the Poison Control Center at 800-222-1222.

Healthcare professionals should advise patients to discontinue use and consult a physician if any of the following conditions occur: muscle aches or pain that persist for more than 7 days or recur, or a cough that lasts longer than 7 days, returns, or is accompanied by fever, rash, or a persistent headache. These symptoms may indicate a serious underlying condition that requires further evaluation and management.

Side Effects

Patients using this product should be aware that it is for external use only and must avoid contact with the eyes.

In clinical practice, patients are advised to stop use and consult a healthcare professional if muscle aches or pain persist for more than 7 days or if they recur. Additionally, if a cough lasts more than 7 days, returns, or occurs alongside fever, rash, or headache that persists, these symptoms may indicate a serious underlying condition requiring medical attention.

Before using this product, patients should seek medical advice if they have a history of asthma, excessive phlegm (mucus), emphysema, a persistent or chronic cough, or a cough associated with smoking.

Drug Interactions

No specific drug interactions have been identified in the available data. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on the current information.

Packaging & NDC

Below are the non-prescription pack sizes of Theracare Medicated Chest Rub (camphor, menthol, eucalyptus oil). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 2 years of age should consult a healthcare professional before using this product. For children aged 2 years and older, the recommended application involves rubbing a thick layer on the chest and throat or on sore, aching muscles. If desired, the area may be covered with a dry soft cloth, ensuring that clothing remains loose. This application can be repeated up to three times daily.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional before using this medication. The safety of this drug during pregnancy has not been established, and potential risks to fetal outcomes are not fully known. Therefore, it is essential for women of childbearing potential to seek medical advice prior to use to ensure appropriate management and consideration of any potential risks.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage in the provided sections of the Summary of Product Characteristics (SPL), healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdosage.

Recommended Actions In the event of an overdosage, it is essential for healthcare providers to assess the patient's clinical status and initiate appropriate supportive care. Monitoring of vital signs and symptomatic treatment should be implemented as necessary.

Potential Symptoms While specific symptoms of overdosage are not detailed, healthcare professionals should remain vigilant for any unusual or severe reactions that may arise, given the variability in individual responses to medication.

Management Procedures In the absence of specific antidotes or treatment protocols, the management of overdosage should focus on supportive care and symptomatic relief. Healthcare professionals are encouraged to consult local poison control centers or toxicology experts for guidance tailored to the specific circumstances of the case.

It is imperative that healthcare providers document any instances of overdosage and report them to the appropriate regulatory authorities to contribute to the ongoing assessment of the safety profile of the medication.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question. Further studies may be necessary to fully evaluate the nonclinical toxicology profile.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact the Poison Control Center at 800-222-1222 in the event of accidental ingestion of the product. Patients should be instructed to discontinue use and consult a doctor if muscle aches or pain persist for more than 7 days or if they recur.

Additionally, patients should be informed to stop using the product and seek medical advice if a cough lasts longer than 7 days, returns, or is accompanied by fever, rash, or a headache that persists, as these symptoms may indicate a serious condition.

It is important to communicate to patients that while using this product, they should avoid heating, microwaving, or using it near an open flame. Patients should also be cautioned against adding the product to hot water or any container where heating water could lead to splattering and potential burns.

Healthcare providers should encourage patients to consult a doctor prior to using the product if they have a history of asthma, excessive phlegm (mucus), emphysema, a persistent or chronic cough, or a cough associated with smoking.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers assigned for identification. It is essential to store the product at room temperature to maintain its integrity and efficacy. No special handling requirements are noted; however, standard precautions should be observed to ensure optimal storage conditions.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Theracare Medicated Chest Rub, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)